Completeness of measles case reporting: Review of estimates for the United States

Journal of Infectious Diseases

Volumn 189, Issue SUPPL. 1, 2004, Pages

  Harpaz, Rafael ^a  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; MEASLES VACCINE;

COMMUNITY CARE; HEALTH CARE; HOSPITAL; HUMAN; INCIDENCE; LABORATORY TEST; MEASLES; PHYSICIAN; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; UNITED STATES;

EID: 2442423246     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/378501     Document Type: Review

References (32)

1. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep 1997; 46(RR-10):1-55.
2. Roush MT, Birkhead G, Koo, D, Cobb A, Fleming D. Mandatory reporting of diseases and conditions by health care professionals and laboratories. JAMA 1999; 282:164-70.
3. Güris D, Harpaz R, Redd SB, Smith NJ, Papania MJ. Measles surveillance in the United States: an overview. J Infect Dis 2004; 189(Suppl 1):177-84.
4. Thacker SB, Berkelman RL. Public health surveillance in the United States. Epidemiol Rev 1988; 10:164-90.
5. Haward RA. Scale of under notification of infectious diseases by general practitioners. Lancet 1973; 1:873-4.
6. Thacker SB, Choi K, Brachman PS. The surveillance of infectious diseases. JAMA 1983; 249:1181-5.
7. Schramm M, Vogt RL, Mamolen M. Disease surveillance in Vermont: who reports? Public Health Rep 1991; 106:95-7.
8. Harkess JR, Gildon BA, Archer PW, Istre GR. Is passive surveillance always insensitive? An evaluation of shigellosis surveillance in Oklahoma. Am J Epidemiol 1988; 128:878-81.
9. Konowitz PM, Petrossian GA, Rose DN. The under reporting of disease and physicians' knowledge of reporting requirements. Public Health Rep 1984; 99:31-5.
10. Vogt RL, Larue D, Klauke DN, Jillson DA. Comparison of an active and passive surveillance system of primary care providers for hepatitis, measles, rubella, and salmonellosis in Vermont. Am J Public Health 1983; 73:795-7.
11. Hinman AR, Brandling-Bennett AD, Bernier RH, et al. Current features of measles in the United States: feasibility of measles elimination. Epidemiol Rev 1980; 2:153-70.
12. Bean JA, Burmeister LF, Paule CL, Isaacson P. A comparison of national infection and immunization estimates for measles and rubella. Am J Public Health 1971; 61:2304-10.
13. Hedrich AW. The corrected average attack rate from measles among city children. Am J Hyg 1930; 11:576-300.
14. Los Angeles County Department of Health Services. Disease reporting - a health professional's responsibility. Public Health Lett 1980; 2: S1-3.
15. Sydenstricker E. A study of illness in a general population group. Hagerstown morbidity studies no. I: the method of study and general results. Public Health Rep 1926; 41:2069-38.
16. Sydenstricker E. The reporting of notifiable diseases in a typical small city. Hagerstown morbidity studies no. II. Public Health Rep 1926; 41: 2186-91.
17. Cherry JD, Feigin RD, Lobes LA Jr, et al. Urban measles in the vaccine era: a clinical, epidemiologic, and serologic study. J Pediatr 1972; 81: 217-30.
18. Ewert DP, Westman S, Frederick PD, Waterman SH. Measles reporting completeness during a community-wide epidemic in inner-city Los Angeles. Public Health Rep 1995; 110:161-5.
19. Ewert DP, Frederick PD, Run GHF, Mascola L. The reporting efficiency of measles by hospitals in Los Angeles County, 1986 and 1989. Am J Public Health 1994; 84:868-9.
20. Davis SF, Strebel PM, Atkinson WL, et al. Reporting efficiency during a measles outbreak in New York City, 1991. Am J Public Health 1993; 83: 1011-5.
21. Nordin JD, Harpaz R, Harper P, Rush W. Syndromic surveillance for measles-like illnesses in a managed care setting. J Infect Dis 2004; 189(Suppl 1):222-6.
22. Langmuir AD. Medical importance of measles. Am J Dis Child 1962; 103:224-6.
23. Chen RT, Glasser JW, Rhodes PH, et al. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics 1997; 99:765-73.
24. Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002; 287:606-11.
25. Lenaway DD, Ambler A. Evaluation of a school-based influenza surveillance system. Public Health Rep 1995; 110:333-7.
26. Davis JP, Pfeiffer JA. Surveillance of communicable diseases in child day care settings. Rev Infect Dis 1986; 8:613-7.
27. Markowitz LE, Tomasi A, Sirotkin BI, et al. Measles hospitalizations, United States, 1977-84: comparison with national surveillance data. Am J Public Health 1987; 77:866-8.
28. Harpaz R, Papania MJ. Can a minimum rate of investigation of measles-like illnesses serve as a standard for evaluating measles surveillance? J Infect Dis 2004; 189(Suppl 1):204-9.
29. Harpaz R, Papania MJ, Fujii KE, et al. Lessons learned from establishing and evaluating indicators of the quality of measles surveillance in the United States, 1996-1998. J Infect Dis 2004; 189(Suppl 1):196-203.
30. Harpaz R, Papania MJ, McCauley MM, Redd SB. Has surveillance been adequate to detect endemic measles in the United States? J Infect Dis 2004; 189(Suppl 1):191-5.
31. Effler P, Ching-Lee M, Bogard A, Ieong MC, Nekomoto T, Jernigan D. Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with conventional methods. JAMA 1999; 282:1845-50.
32. Papania MJ, Seward JF, Redd SB, Lievano F, Harpaz R, Wharton ME. The epidemiology of measles in the United States, 1997-2001. J Infect Dis 2004; 189(suppl):61-8.